Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
about
CXCR4 over-expression and survival in cancer: a system review and meta-analysisVascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma.C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.CXCL12/CXCR4 display an inverse mRNA expression profile in gastric carcinoma that correlates with tumor progressionClinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancerCell surface markers in colorectal cancer prognosis.Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells.Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue.Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells.Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.The role of tumour stroma in colorectal cancer invasion and metastasis.A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis".Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis'.
P2860
Q28084663-F9AD998C-349A-4943-862E-A9D51343D2ABQ33553482-9316776D-120E-4C38-A60D-6489E04A8001Q34628723-A67AA8B1-6DBF-4E7B-B23D-EE0CA7FC0CCEQ35111874-1BC36B68-04A2-401B-B7FF-550579F2C8AAQ36156092-993D113F-9B4A-4EAF-83BE-FA2FA2240A72Q36287809-92EFF8CB-7A85-4A89-827C-50F9B9FA6E53Q36407074-BAA6C63F-8CBA-4B2C-A815-0101EA6A490DQ36502915-2B09E126-518D-4A6B-B085-5E168D73EABDQ36954080-6810C805-BDD7-4D2F-A58A-652328516A61Q37845669-527E3AD3-FA78-4F15-87B2-F66B2306C3F9Q38814109-627B9CE9-415D-46AA-859C-1406C79A70BFQ39459322-899CF0B1-CA7D-4A5F-917E-93E79678E8E0Q39489655-6919E6D3-758F-4117-8845-FE8275CF8CA0Q39543648-51742BA0-3BA0-4F23-AF1E-7954A92A8008Q42036102-72D3E189-2BDE-49F8-B0BA-9D9374FC350EQ42576948-597B3D80-A31D-4234-9313-E3968DD85955Q44412713-D227C19F-E4F3-4D55-ADC7-A32AE9F14AC2Q46440631-370AFE92-C315-4B4A-A971-0D84FBB6090AQ50192175-F013E0EC-5419-40AB-8CAA-2DFDF5B6634BQ50192183-1F5FC33A-CB52-42DF-AE0F-29D7D9D72950
P2860
Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@en
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@nl
type
label
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@en
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@nl
prefLabel
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@en
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@nl
P2093
P1476
Stromal CXCR4 and CXCL12 expre ...... ancer after chemoradiotherapy.
@en
P2093
Aya Kawamoto
Chikao Miki
Hiromi Yasuda
Koji Tanaka
Masato Kusunoki
Susumu Saigusa
Takeshi Yokoe
Yasuhiro Inoue
Yoshinaga Okugawa
Yuji Toiyama
P2888
P304
P356
10.1245/S10434-010-0970-Y
P577
2010-02-23T00:00:00Z
P6179
1042188864